Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ADX:JULPHAR'
s EV-to-FCF Range Over the Past 10 Years
Min: -561.72 Med: 15.3 Max: 1547.06
Current: 14.2
During the past 13 years, the highest EV-to-FCF of Gulf Pharmaceutical Industries PSC was 1547.06. The lowest was -561.72. And the median was 15.30.
ADX:JULPHAR's EV-to-FCF is ranked better than 55.56% of 72
companies
in the Medical Distribution industry
Industry Median: 17.36
vs ADX:JULPHAR: 14.20
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Gulf Pharmaceutical Industries PSC's PE Ratio (TTM) for today is calculated as:
Gulf Pharmaceutical Industries PSC's share price for today is د.إ1.04.
Gulf Pharmaceutical Industries PSC's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was د.إ0.058.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Gulf Pharmaceutical Industries PSC EV-to-FCF Related Terms
Gulf Pharmaceutical Industries PSC EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ADX:JULPHAR vs MCK, COR, CAH: EV-to-FCF Comparison
For the Medical Distribution subindustry, Gulf Pharmaceutical Industries PSC's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gulf Pharmaceutical Industries PSC EV-to-FCF vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Gulf Pharmaceutical Industries PSC's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Gulf Pharmaceutical Industries PSC's EV-to-FCF falls into.
Gulf Pharmaceutical Industries PSC's current Enterprise Value is د.إ1,225 Mil.
Gulf Pharmaceutical Industries PSC's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was د.إ87 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) has a EV-to-FCF of 14.06 as of Aug. 02, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Gulf Pharmaceutical Industries PSC and its competitors. This is near median its historical median of 15.30. According to the industry distribution chart, Gulf Pharmaceutical Industries PSC ranks #32 out of 72 companies in the Medical Distribution industry, placing it in the top 44.4%.
Is Gulf Pharmaceutical Industries PSC's EV-to-FCF too high?
Gulf Pharmaceutical Industries PSC's current EV-to-FCF of 14.06 is near median its 10-year median of 15.30. The Medical Distribution industry median EV-to-FCF is 17.36. Gulf Pharmaceutical Industries PSC's value of 14.06 is 19% below this industry median. Based on the distribution chart, Gulf Pharmaceutical Industries PSC ranks #32 out of 72 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Gulf Pharmaceutical Industries PSC has a GF Score™ of 54/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Gulf Pharmaceutical Industries PSC's EV-to-FCF compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Gulf Pharmaceutical Industries PSC ranks #32 out of 72 companies for EV-to-FCF. This puts Gulf Pharmaceutical Industries PSC in the upper half of its industry. The industry median EV-to-FCF is 17.36. Gulf Pharmaceutical Industries PSC's value of 14.06 is 19% below this benchmark. While the company's 10-year median is 15.30 vs. the industry median of 17.36, Gulf Pharmaceutical Industries PSC has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Distribution company?
The median EV-to-FCF among Medical Distribution companies is 17.36, based on 72 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gulf Pharmaceutical Industries PSC's current EV-to-FCF of 14.06 is 19% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Gulf Pharmaceutical Industries PSC and its competitors. For the Medical Distribution industry, the median EV-to-FCF is 17.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gulf Pharmaceutical Industries PSC's current EV-to-FCF is 14.06, which is near median its own 10-year median of 15.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gulf Pharmaceutical Industries PSC stock overvalued right now?
Based on GuruFocus' analysis, Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) is currently considered Fairly Valued. The stock's GF Value™ is د.إ1.08, compared to a current price of د.إ1.04 — trading 3.7% below its estimated fair value. The current EV-to-FCF is 14.06, which is near median its 10-year median of 15.30 and 19% below the Medical Distribution industry median of 17.36. Gulf Pharmaceutical Industries PSC's overall GF Score™ is 54/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Gulf Pharmaceutical Industries PSC (ADX:JULPHAR), the current EV-to-FCF is 14.06 as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) Overvalued in 2026?
Based on GuruFocus' analysis, Gulf Pharmaceutical Industries PSC stock appears to be undervalued.
The current stock price of د.إ1.04 is trading 3.7% below its estimated GF Value™ of د.إ1.08.
GuruFocus considers Gulf Pharmaceutical Industries PSC to be Fairly Valued.
Key valuation signals for ADX:JULPHAR:
EV-to-FCF: 14.06 (near median its 10-year median of 15.30)
GF Value™: د.إ1.08 vs. price of د.إ1.04 (3.7% below fair value)
Industry Position: 19% below the Medical Distribution median (#32 of 72)
No single metric tells the full story. See the ADX:JULPHAR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Gulf Pharmaceutical Industries PSC is in the business of manufacturing and selling medicines, drugs, and various other types of pharmaceutical and medical compounds in addition to cosmetic compounds. The company operates in four segments: Manufacturing, Trading, Investments, and others. The majority of its revenue is generated from the Manufacturing segment. The geographical segments are UAE, Other GCC countries, and Other countries. It derives maximum revenue from UAE. Its business is centered around General Medicines in the retail pharmacy channel and hospitals as well as speciality Products. Its medicines also targets therapeutic segments such as Diabetes, Gastrointestinal Tract (GIT), Respiratory, Wounds and Scars, Anti-infectives, Anemia, Gynecology, Erectile Dysfunction and Others.
54GF Score
Get the complete analysis for ADX:JULPHAR
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ADX:JULPHAR has been successfully added to your 
